Eli Lilly's stock offers high growth potential, driven by GLP-1 therapies and strong R&D efforts. Read why LLY stock is ...
Market breadth has been a bit of a problem. It is our most negative indicator. Even when SPX made a new all-time high for the second day (Feb. 19), breadth was negative in both NYSE and "stocks only" ...